Left Atrial Appendage Occlusion and Biomarker Evaluation "LABEL"


Phase N/A Results N/A

Summary of Purpose

"Left Atrial Appendage Occlusion and Biomarker Evaluation" (LABEL) is a single-center, prospective and observational study evaluating changes of the expression of biomarkers in eligible patients before and after percutaneous implantation of a left atrial appendage (LAA) occlusion device at mid-term follow-up.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 7 December 2016.

1 Jun 2014 3 Dec 2016 1 Dec 2020 Unavailable 1 Dec 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available